Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Red River Bancshares, Inc. Reports Fourth Quarter 2025 Financial Results
-
Pacific Financial Corp Reports Fourth Quarter 2025 Earnings of $3.1 Million, or $0.31 per Diluted Share; Declares Quarterly Cash Dividend of $0.15 per Share
-
Hudson Technologies Provides Update on Status of Defense Logistics Agency Contract
-
Actelis Networks Receives Significant Expansion Order from Major European Natural Gas Operator, Continuing Critical Infrastructure Modernization
-
Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-8 (PCP), Indicating Potential in Prostate Cancer Prevention and Metabolic Value
-
AlphaTON’s Claude Connector Accelerates User Shift Away From Big Tech AI Practices That Steal Ideas and Data
-
Saratoga Investment Corp. Prices Public Offering of $100 Million 7.50% Notes Due 2031
-
Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) to U.S. FDA
-
IperionX – December 2025 Quarterly Report
-
Apollo Commercial Real Estate Finance, Inc. Announces Dates for Fourth Quarter and Year End 2025 Earnings Release and Conference Call
-
BCB Bancorp, Inc. Reports Net Loss of $12.0 Million in Fourth Quarter 2025
-
Kingstone Declares Quarterly Dividend
-
Reliance Global Group Reports 72% Increase in Health Insurance Policies Written Through RELI Exchange During 2025 Open Enrollment
-
WISeSat.Space Brought Together Global Thought-Leaders to Davos to Address Quantum Security in Space
-
Notice To Long-Term Shareholders of Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
-
Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
-
Edible Garden’s Gourmet Greens Hydroponic Basil Now Available at Hannaford
-
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles
-
Star Group, L.P. to Host Fiscal 2026 First Quarter Webcast and Conference Call February 5, 2026
-
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer
-
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
-
PropQwiz Awards Life-Changing $350,000 Grand Prize to First Winner, a Las Vegas Mother
-
IO Biotech Provides Corporate Update
-
Changes in the Management Board of Nordic Fibreboard AS
-
Purchase, George & Murphey Attorney Eric Purchase Volunteers as Judge at Erie County PBA Mock Trial Competition
-
Volaris Automotive Acquires TSI Auto Solutions
-
Orion Announces Pricing of Public Offering of Common Stock
-
German Car Depot Launches Mercedes Oil Change Appointments Designed Around A & B Service Maintenance Needs
-
LGI Homes Announces New Community in the Modesto, California Market
-
Nuwellis Appoints Carisa Schultz as Chief Financial Officer
-
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
-
GraniteShares Announces Weekly Distributions for its YieldBOOST FoFs ETFs: YBST and YBTY
-
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
-
Gentex Reports Fourth Quarter And Year End 2025 Financial Results
-
Horizon Space Acquisition II Corp. Postponed the Extraordinary General Meeting to February 12, 2026 and Extended the Redemption Request Deadline
-
Goranson Bain Ausley Welcomes Collaborative Family Law Attorney Jill Lowe to Plano Office
-
First Hawaiian, Inc. Reports Fourth Quarter 2025 Financial Results and Declares Dividend
-
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
-
Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Third Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending April, May, and J
-
CIRM approves new $100 million plan to accelerate genetic therapies for patients with rare diseases
-
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Edible Garden Announces Reverse Stock Split of the Company’s Common Stock
-
Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq
-
Westwood Holdings Group, Inc. to Host Fourth Quarter and Fiscal Year 2025 Conference Call/Webcast
-
IES Holdings Reports Fiscal 2026 First Quarter Results
-
Centerra Gold Reports Explosion at Langeloth; No Fatalities or Significant Environmental Releases
-
CN Announces New Normal Course Issuer Bid for Share Repurchase and 3% Dividend Increase
-
HPQ Confirms Fumed Silica Produced With Pilot Scale Reactor is Independently Verified as Meeting Commercial Grade “150”
-
Bonaccord Capital Partners Named 2025 Middle Market GP Stakes Firm of the Year by GP Stakes News
-
Max Power Prepares to Drill Second Natural Hydrogen Well as Program Expands 325 km SW of Lawson Discovery
